Aquestive Therapeutics, Inc. (AQST) vs Ironwood Pharmaceuticals, Inc. (IRWD)

Aquestive Therapeutics, Inc. and Ironwood Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Ironwood Pharmaceuticals, Inc. is the larger, with a market value of $692.4M against $605.0M — 1.1× the size. Aquestive Therapeutics, Inc. has negative trailing earnings, so its P/E is not meaningful; Ironwood Pharmaceuticals, Inc. trades at 5.2×. Ironwood Pharmaceuticals, Inc. grew revenue faster over the last twelve months: 26.2% against 22.6%. Ironwood Pharmaceuticals, Inc. has the higher net margin (33.4% vs −144.6%) and the higher return on invested capital (101.6% vs 0.00%). Across the 18 metrics below, Ironwood Pharmaceuticals, Inc. leads on 13 and Aquestive Therapeutics, Inc. on 5.

Valuation

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
P/E n/m 5.18 20.14
P/S 10.82 1.74 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m 3.66 16.54
EV/EBITDA n/m 5.02 12.29
EV/Sales 9.93 3.04 2.56
Earnings yield (13.89%) 19.31% (2.99%)
Free cash flow yield (7.85%) 27.32% 0.00%

Profitability

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
Gross margin 67.04% 100.00% 53.94%
Operating margin (97.52%) 60.15% 0.00%
Net margin (144.63%) 33.36% 0.00%
Free cash flow margin (84.95%) 47.66% 0.00%
Return on equity 121.12% (55.26%) (0.40%)
Return on assets (69.29%) 41.35% (3.32%)
Return on invested capital 0.00% 101.61% 0.00%

Growth

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 22.56% 26.19% 10.01%
EPS growth (last fiscal year) (52.94%) 2,627.27% —
Revenue growth, 5-year CAGR (0.58%) (5.33%) 6.74%
Net income growth, 5-year CAGR 0.00% (25.72%) 0.00%

Health

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
Debt to equity (0.90) (2.38) 0.05
Current ratio 7.19 6.06 2.31
Net debt to EBITDA 1.57 3.68 0.85

Dividend

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio 0.00 0.00 0.00

Size

Metric AQST IRWD Drug Manufacturers Specialty & Generic median
Market cap 604.97m 692.36m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack